Julie Parsonnet

5.0/5

4 Patient Ratings

47 Patient Reviews

Julie Parsonnet

Infectious diseases doctor

George DeForest Barnett Professor of Medicine and Professor of Epidemiology and Population Health

View Professional Summary

Additional Languages Spoken:

French , Spanish

Insurance Coverage

Resources for Referring Physicians

Biography

Dr. Parsonnet is an Infectious Diseases clinician and epidemiologist whose research focuses on the role of infections in chronic disease. Her early work was pivotal in establishing H. pylori as a cause of gastric cancer and gastric lymphoma as well as protective effects of infections against esophageal diseases. More recently, she has focused on how exposures to infectious agents affects metabolism, growth and human body temperature. Dr. Parsonnet also has clinical interests in tuberculosis and in coccidioidomycosis. Dr. Parsonnet has had more than 30 years of continuous NIH funding. She is a member of the National Academy of Medicine, Association of American Physicians, American Epidemiological Society, the American Society for Clinical Investigation and is a Fellow of the Infectious Diseases Society of America. Outside of Stanford, Dr. Parsonnet is on the Board of Directors of Doctors for America and is President of SAFE, an NGO of healthcare providers dedicated to reducing firearms injuries and deaths.

View Full Biography

Professional Summary

Education & Certifications

Medical Education: Weill Cornell Medical College (1983) NY
Fellowship: Massachusetts General Hospital (1989) MA
Board Certification: American Board of Internal Medicine, Infectious Disease (1988)
- Residency: Massachusetts General Hospital (1987) MA
- Board Certification: American Board of Internal Medicine, Internal Medicine (1986)
- Residency: Massachusetts General Hospital (1986) MA
- Internship: Massachusetts General Hospital (1984) MA
- M.D., Cornell, Medicine (1983)
- A.B., Harvard, History and Science (1979)

View More Education & Certifications

Honors & Awards

Best Doctors in the U.S, Best Doctors (2001, 2005. 2007, 2010-16)
George DeForest Barnett Professorship, Stanford (2005-)
Henry J. Kaiser Award for Innovation in Medical Education, Stanford University (2004)
- Henry J. Kaiser Family Foundation Award for Excellence in Preclinical Teaching, Stanford University (2002)
- Member, American Society for Clinical Investigation (1998)
- Member, Association of American Physicians (2017-)
- Member, National Academy of Medicine (2019-)

View More Honors & Awards

Memberships

Member, American Epidemiological Association (1999 - Present)
Member, American Society for Clinical Investigation (1998 - Present)
Fellow, Infectious Diseases Society of America (1995 - Present)
- Member, Research Committee, Infectious Diseases Society of America (2013 - Present)
- MID-B Study Section Standing Member, NIH (2011 - 2016)
- Scientific Advisory Board, Thrasher Foundation (2006 - 2011)

View More Memberships

Administrative Appointments

Chief, Infectious Diseases and Geographic Medicine, Stanford, Department of Medicine (1998 - 2001)
Sr. Associate Dean for Medical Education, Stanford University (2001 - 2006)
Steering Committee of Faculty Senate, Stanford University (2016 - Present)

Publications

Patterns of health seeking behavior during episodes of childhood diarrhea: a study of Tzotzil-speaking Mayans in the highlands of Chiapas, Mexico
Granich, R., Cantwell, M. F., Long, K., Maldonado, Y., & Parsonnet, J. (1999). Patterns of health seeking behavior during episodes of childhood diarrhea: a study of Tzotzil-speaking Mayans in the highlands of Chiapas, Mexico. SOCIAL SCIENCE & MEDICINE, 48(4), 489–495.
Rhesus monkey (Macaca mulatta) model of Helicobacter pylori: Noninvasive detection and derivation of specific-pathogen-free monkeys
Solnick, J. V., Canfield, D. R., Yang, S. F., & Parsonnet, J. (1999). Rhesus monkey (Macaca mulatta) model of Helicobacter pylori: Noninvasive detection and derivation of specific-pathogen-free monkeys. LABORATORY ANIMAL SCIENCE, 49(2), 197–201.
Helicobacter pylori virulence and genetic geography
Covacci, A., Telford, J. L., Del Giudice, G., Parsonnet, J., & Rappuoli, R. (1999). Helicobacter pylori virulence and genetic geography. SCIENCE, 284(5418), 1328–1333.
- Helicobacter pylori and gastric cancer: What are the benefits of screening only for the CagA phenotype of H. pylori?
  Harris, R. A., Owens, D. K., Witherell, H., & Parsonnet, J. (1999). Helicobacter pylori and gastric cancer: What are the benefits of screening only for the CagA phenotype of H. pylori? HELICOBACTER, 4(2), 69–76.
- Prevalence and incidence of herpes simplex virus type 2 infection among male Zimbabwean factory workers
  McFarland, W., Gwanzura, L., Bassett, M. T., Machekano, R., Latif, A. S., Ley, C., … KATZENSTEIN, D. (1999). Prevalence and incidence of herpes simplex virus type 2 infection among male Zimbabwean factory workers. JOURNAL OF INFECTIOUS DISEASES, 180(5), 1459–1465.
- Helicobacter pylori vaccine development and use: A cost-effectiveness analysis using the institute of medicine methodology
  Rupnow, M. F. T., Owens, D. K., Shachter, R., & Parsonnet, J. (1999). Helicobacter pylori vaccine development and use: A cost-effectiveness analysis using the institute of medicine methodology. HELICOBACTER, 4(4), 272–80.
- Fecal and oral shedding of Helicobacter pylori from healthy infected adults
  Parsonnet, J., Shmuely, H., & Haggerty, T. (1999). Fecal and oral shedding of Helicobacter pylori from healthy infected adults. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 282(23), 2240–2245.
- When heredity is infectious
  Parsonnet, J. (2000). When heredity is infectious. GASTROENTEROLOGY, 118(1), 222–224.
- Interobserver variability in application of the revised Sydney classification for gastritis
  Guarner, J., Herrera-Goepfert, R., Mohar, A., Sanchez, L., Halperin, D., Ley, C., & Parsonnet, J. (1999). Interobserver variability in application of the revised Sydney classification for gastritis. HUMAN PATHOLOGY, 30(12), 1431–1434.
- A dynamic transmission model for predicting trends in Helicobacter pylori and associated diseases in the United States
  Rupnow, M. F. T., Shachter, R. D., Owens, D. K., & Parsonnet, J. (2000). A dynamic transmission model for predicting trends in Helicobacter pylori and associated diseases in the United States. EMERGING INFECTIOUS DISEASES, 6(3), 228–37.
- Gastric atrophy and extent of intestinal metaplasia in a cohort of Helicobacter pylori-infected patients
  Guarner, J., Herrera-Goepfert, R., Mohar, A., Sanchez, L., Halperin, D., Ley, C., & Parsonnet, J. (2001). Gastric atrophy and extent of intestinal metaplasia in a cohort of Helicobacter pylori-infected patients. HUMAN PATHOLOGY, 32(1), 31–35.
- Confirmatory serologic testing for acute toxoplasmosis and rate of induced abortions among women reported to have positive Toxoplasma immunoglobulin M antibody titers
  Liesenfeld, O., Montoya, J. G., Tathineni, N. J., Davis, M., Brown, B. W., Cobb, K. L., … Remington, J. S. (2001). Confirmatory serologic testing for acute toxoplasmosis and rate of induced abortions among women reported to have positive Toxoplasma immunoglobulin M antibody titers. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. SAN FRANCISCO,CA,CA,CA,CA,CA: MOSBY-ELSEVIER.
- Histological classification of gastric adenocarcinoma for epidemiological research: Concordance between pathologists
  Shibata, A., Longacre, T. A., Puligandla, B., Parsonnet, J., & Habel, L. A. (2001). Histological classification of gastric adenocarcinoma for epidemiological research: Concordance between pathologists. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 10(1), 75–78.
- Screening markers for chronic atrophic gastritis in Chiapas, Mexico
  Ley, C., Mohar, A., Guarner, J., Herrera-Goepfert, R., Figueroa, L. S., Halperin, D., & Parsonnet, J. (2001). Screening markers for chronic atrophic gastritis in Chiapas, Mexico. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 10(2), 107–112.
- Helicobacter pylori infection and gastric cancer
  Ley, C., & Parsonnet, J. (2001). Helicobacter pylori infection and gastric cancer. GASTROENTEROLOGY, 120(1), 324–324.
- Variability of serologic testing for H-pylori using US and Peruvian antigens
  De Arruda, S. M. B., Passaro, D. J., Yang, S. F., & Parsonnet, J. (2001). Variability of serologic testing for H-pylori using US and Peruvian antigens. GASTROENTEROLOGY, 120(1), 325–326.
- Helicobacter pylori and risk for gastric adenocarcinoma.
  Asghar, R. J., & Parsonnet, J. (2001). Helicobacter pylori and risk for gastric adenocarcinoma. Seminars in Gastrointestinal Disease, 12(3), 203–208.
- Is anything safe to eat?
  SOBEL, J., Swerdlow, D. L., & Parsonnet, J. (2001). Is anything safe to eat? Current Clinical Topics in Infectious Diseases, 21, 114–134.
- Determination of the infectious dose of Helicobacter pylori during primary and secondary infection in rhesus monkeys (Macaca mulatta)
  Solnick, J. V., Hansen, L. M., Canfield, D. R., & Parsonnet, J. (2001). Determination of the infectious dose of Helicobacter pylori during primary and secondary infection in rhesus monkeys (Macaca mulatta). INFECTION AND IMMUNITY, 69(11), 6887–6892.
- Acute Helicobacter pylori infection is followed by an increase in diarrheal disease among Peruvian children.
  Passaro, D. J., TAYLOR, D. N., MEZA, R., Cabrera, L., Gilman, R. H., & Parsonnet, J. (2001). Acute Helicobacter pylori infection is followed by an increase in diarrheal disease among Peruvian children. Pediatrics, 108(5), E87-?
- Quantifying the population impact of a prophylactic Helicobacter pylori vaccine
  Rupnow, M. F. T., Shachter, R. D., Owens, D. K., & Parsonnet, J. (2001). Quantifying the population impact of a prophylactic Helicobacter pylori vaccine. VACCINE, 20(5-6), 879–85.
- CagA status of Helicobacter pylori infection and p53 gene mutations in gastric adenocarcinoma
  Shibata, A., Parsonnet, J., Longacre, T. A., Garcia, M. I., Puligandla, B., Davis, R. E., … Habel, L. A. (2002). CagA status of Helicobacter pylori infection and p53 gene mutations in gastric adenocarcinoma. CARCINOGENESIS, 23(3), 419–24.
- Validation of Spanish Language Dyspepsia Questionnaire
  Goldman, J., Conrad, D. F., Ley, C., Halperin, D., Sanchez, M. D. L., Villacorta, R., & Parsonnet, J. (2002). Validation of Spanish Language Dyspepsia Questionnaire. DIGESTIVE DISEASES AND SCIENCES, 47(3), 624–40.
- A modification of the quininium resin test for assessing gastric acidity
  Passaro, D. J., Hurwitz, A., Triadafilopoulos, G., & Parsonnet, J. (2002). A modification of the quininium resin test for assessing gastric acidity. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 16(5), 875–880.
- Helicobacter pylori: Consensus and controversy
  Passaro, D. J., Chosy, E. J., & Parsonnet, J. (2002). Helicobacter pylori: Consensus and controversy. CLINICAL INFECTIOUS DISEASES, 35(3), 298–304.
- Eradication rate of Helicobacter pylori in a Mexican population at high risk for gastric cancer and use of serology to assess cure
  Mohar, A., Ley, C., Guarner, J., Herrera-Goepfert, R., Figueroa, L. S., Halperin, D., & Parsonnet, J. (2002). Eradication rate of Helicobacter pylori in a Mexican population at high risk for gastric cancer and use of serology to assess cure. AMERICAN JOURNAL OF GASTROENTEROLOGY, 97(10), 2530–2535.
- Growth slowing after acute Helicobacter pylori infection is age-dependent
  Passaro, D. J., TAYLOR, D. N., Gilman, R. H., Cabrera, L., & Parsonnet, J. (2002). Growth slowing after acute Helicobacter pylori infection is age-dependent. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 35(4), 522–26.
- [High frequency of precancerous lesions of gastric cancer associated with Helicobacter pylori and response to treatment, in Chiapas, Mexico].
  Mohar, A., Ley, C., Guarner, J., Herrera-Goepfert, R., Sánchez, L., Halperin, D., & Parsonnet, J. (2002). [High frequency of precancerous lesions of gastric cancer associated with Helicobacter pylori and response to treatment, in Chiapas, Mexico]. Gaceta Médica De México, 138(5), 405–410.
- Helicobacter pylori in cathartic stools of subjects with and without cimetidine-induced hypochlorhydria
  Haggerty, T., Shmuely, H., & Parsonnet, J. (2003). Helicobacter pylori in cathartic stools of subjects with and without cimetidine-induced hypochlorhydria. JOURNAL OF MEDICAL MICROBIOLOGY, 52(2), 189–91.
- C-reactive protein, Helicobacter pylori, Chlamydia pneumoniae, cytomegalovirus and risk for myocardial infarction
  Witherell, H. L., Smith, K. L., Friedman, G. D., Ley, C., Thom, D. H., Orentreich, N., … Parsonnet, J. (2003). C-reactive protein, Helicobacter pylori, Chlamydia pneumoniae, cytomegalovirus and risk for myocardial infarction. ANNALS OF EPIDEMIOLOGY, 13(3), 170–77.
- Diagnostic yield of gastric biopsy specimens when screening for preneoplastic lesions
  Guarner, J., Herrera-Goepfert, R., Mohar, A., Smith, C., Schofield, A., Halperin, D., … Parsonnet, J. (2003). Diagnostic yield of gastric biopsy specimens when screening for preneoplastic lesions. HUMAN PATHOLOGY, 34(1), 28–31.
- No association between Helicobacter pylori and Mycobacterium tuberculosis infections among gastrointestinal clinic attendees in Lima, Peru
  Torres, M. A., Passaro, D. J., Watanabe, J., Parsonnet, J., Small, P., Miyagui, J., … Gilman, R. H. (2003). No association between Helicobacter pylori and Mycobacterium tuberculosis infections among gastrointestinal clinic attendees in Lima, Peru. EPIDEMIOLOGY AND INFECTION, 130(1), 87–91.
- Variability in antibiotic prescribing patterns and outcomes in patients with clinically suspected ventilator-associated pneumonia
  Fowler, R. A., Flavin, K. E., Barr, J., Weinacker, A. B., Parsonnet, J., & Gould, M. K. (2003). Variability in antibiotic prescribing patterns and outcomes in patients with clinically suspected ventilator-associated pneumonia. CHEST, 123(3), 835–44.
- What is the Helicobacter pylori global reinfection rate?
  Parsonnet, J. (2003). What is the Helicobacter pylori global reinfection rate? Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie, 17, 46B–48B.
- SALT INTAKE AND STOMACH-CANCER - SOME CONTRARY EVIDENCE
  Friedman, G. D., & Parsonnet, J. (1992). SALT INTAKE AND STOMACH-CANCER - SOME CONTRARY EVIDENCE. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 1(7), 607–608.
- Natural acquisition of Helicobacter pylori infection in newborn rhesus Macaques
  Solnick, J. V., Chang, K., Canfield, D. R., & Parsonnet, J. (2003). Natural acquisition of Helicobacter pylori infection in newborn rhesus Macaques. JOURNAL OF CLINICAL MICROBIOLOGY, 41(12), 5511–16.
- Helicobacter pylori infection and gastric cancer - For want of more outcomes
  Parsonnet, J., & Forman, D. (2004). Helicobacter pylori infection and gastric cancer - For want of more outcomes. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 291(2), 244–245.
- Bacterial infection and MALT lymphoma
  Parsonnet, J., & Isaacson, P. G. (2004). Bacterial infection and MALT lymphoma. NEW ENGLAND JOURNAL OF MEDICINE, 350(3), 213–15.
- Helicobacter pylori eradication and gastric preneoplastic conditions: A randomized, double-blind, placebo-controlled trial
  Ley, C., Mohar, A., Guarner, J., Herrera-Goepfert, R., Figueroa, L. S., Halperin, D., … Parsonnet, J. (2004). Helicobacter pylori eradication and gastric preneoplastic conditions: A randomized, double-blind, placebo-controlled trial. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 13(1), 4–10.
- Antimicrobial resistance incidence and risk factors among Helicobacter pylori-infected persons, United States
  Duck, W. M., SOBEL, J., Pruckler, J. M., Song, O. S., Swerdlow, D., Friedman, C., … Gold, B. D. (2004). Antimicrobial resistance incidence and risk factors among Helicobacter pylori-infected persons, United States. EMERGING INFECTIOUS DISEASES, 10(6), 1088–1094.
- Helicobacter pylori and risk of gastroenteritis
  Perry, S., Sanchez, L., Yang, S. F., Haggerty, T. D., Hurst, P., & Parsonnet, J. (2004). Helicobacter pylori and risk of gastroenteritis. JOURNAL OF INFECTIOUS DISEASES, 190(2), 303–10.
- Helicobacter pylori infection and the risk of development of esophageal adenocarcinoma
  de Martel, C., Llosa, A. E., Farr, S. M., Friedman, G. D., Vogelman, J. H., Orentreich, N., … Parsonnet, J. (2005). Helicobacter pylori infection and the risk of development of esophageal adenocarcinoma. JOURNAL OF INFECTIOUS DISEASES, 191(5), 761–67.
- Significance of transiently positive enzyme-linked immunosorbent assay results in detection of Helicobacter pylori in stool samples from children
  Haggerty, T. D., Perry, S., Sanchez, L., Perez-Perez, G., & Parsonnet, J. (2005). Significance of transiently positive enzyme-linked immunosorbent assay results in detection of Helicobacter pylori in stool samples from children. JOURNAL OF CLINICAL MICROBIOLOGY, 43(5), 2220–23.
- Helicobacter pylori infection in different generations of Hispanics in the San Francisco Bay Area
  Tsai, C. J., Perry, S., Sanchez, L., & Parsonnet, J. (2005). Helicobacter pylori infection in different generations of Hispanics in the San Francisco Bay Area. AMERICAN JOURNAL OF EPIDEMIOLOGY, 162(4), 351–57.
- Household transmission of gastroenteritis
  Perry, S., Sanchez, M. D. L., Hurst, P. K., & Parsonnet, J. (2005). Household transmission of gastroenteritis. EMERGING INFECTIOUS DISEASES, 11(7), 1093–96.
- Use of insecticide-treated nets (ITNs) following a malaria education intervention in Piron, Mali: a control trial with systematic allocation of households
  Rhee, M., Sissoko, M., Perry, S., McFarland, W., Parsonnet, J., & Doumbo, O. (2005). Use of insecticide-treated nets (ITNs) following a malaria education intervention in Piron, Mali: a control trial with systematic allocation of households. MALARIA JOURNAL, 4.
- Risk of intestinal helminth and protozoan infection in a refugee population
  Garg, P. K., Perry, S., Dorn, M., Hardcastle, L., & Parsonnet, J. (2005). Risk of intestinal helminth and protozoan infection in a refugee population. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 73(2), 386–91.
- QuantiFERON (R)-TB predicts tuberculin skin test boosting in US foreign-born
  Nguyen, M., Perry, S., & Parsonnet, J. (2005). QuantiFERON (R)-TB predicts tuberculin skin test boosting in US foreign-born. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 9(9), 985–91.
- Cell proliferation and inflammation on biopsy samples with multifocal atrophic gastritis before and 1 year after Helicobacter pylori eradication
  Guarner, J., Bartlett, J., Seitz, R., Whistler, T., Herrera-Goepfert, R., Mohar, A., … Parsonnet, J. (2005). Cell proliferation and inflammation on biopsy samples with multifocal atrophic gastritis before and 1 year after Helicobacter pylori eradication. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 129(11), 1451–1456.
- Concordance of Helicobacter pylori infection among children in extended-family homes
  Garg, P. K., Perry, S., Sanchez, L., & Parsonnet, J. (2006). Concordance of Helicobacter pylori infection among children in extended-family homes. EPIDEMIOLOGY AND INFECTION, 134(3), 450–459.
- Commentary: H. pylori infection in early life and the problem of imperfect tests
  Perry, S., & Parsonnet, J. (2005). Commentary: H. pylori infection in early life and the problem of imperfect tests. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 34(6), 1356–58.
- Clinician-discoverers - Marshall, Warren, and H-Pylori
  Parsonnet, J. (2005). Clinician-discoverers - Marshall, Warren, and H-Pylori. NEW ENGLAND JOURNAL OF MEDICINE, 353(23), 2421–23.
- Validation of the blood quininium resin test for assessing gastric hypochlorhydria
  de Martel, C., Ratanasopa, S., Passaro, D., & Parsonnet, J. (2006). Validation of the blood quininium resin test for assessing gastric hypochlorhydria. DIGESTIVE DISEASES AND SCIENCES, 51(1), 84–88.
- Changes of gene expression in gastric preneoplasia following Helicobacter pylori eradication therapy
  Tsai, C. J., Herrera-Goepfert, R., Tibshirani, R. J., Yang, S. F., Mohar, A., Guarner, J., & Parsonnet, J. (2006). Changes of gene expression in gastric preneoplasia following Helicobacter pylori eradication therapy. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 15(2), 272–80.
- Investigation of mediastinitis due to coagulase-negative staphylococci after cardiothoracic surgery
  Van Kerkhove, M. D., Parsonnet, J., Weingart, M., & Tompkins, L. S. (2006). Investigation of mediastinitis due to coagulase-negative staphylococci after cardiothoracic surgery. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 27(3), 305–7.
- Associations of serologic markers of infection and inflammation with vascular disease events and mortality in American dialysis patients.
  Lentine, K. L., Parsonnet, J., Taylor, I., Wrone, E. M., & Lafayette, R. A. (2006). Associations of serologic markers of infection and inflammation with vascular disease events and mortality in American dialysis patients. Clinical and Experimental Nephrology, 10(1), 55–62.
- MOLECULAR EPIDEMIOLOGIC TECHNIQUES IN ANALYSIS OF EPIDEMIC AND ENDEMIC SHIGELLA-DYSENTERIAE TYPE-1 STRAINS
  STROCKBINE, N. A., Parsonnet, J., Greene, K., KIEHLBAUCH, J. A., & WACHSMUTH, I. K. (1991). MOLECULAR EPIDEMIOLOGIC TECHNIQUES IN ANALYSIS OF EPIDEMIC AND ENDEMIC SHIGELLA-DYSENTERIAE TYPE-1 STRAINS. JOURNAL OF INFECTIOUS DISEASES, 163(2), 406–409.
- Acquisition of Helicobacter pylori infection in rhesus macaques is most consistent with oral-oral transmission
  Solnick, J. V., Fong, J., Hansen, L. M., Chang, K., Canfield, D. R., & Parsonnet, J. (2006). Acquisition of Helicobacter pylori infection in rhesus macaques is most consistent with oral-oral transmission. JOURNAL OF CLINICAL MICROBIOLOGY, 44(10), 3799–3803.
- Helicobacter pylori infection and gender: A meta-analysis of population-based prevalence surveys
  de Martel, C., & Parsonnet, J. (2006). Helicobacter pylori infection and gender: A meta-analysis of population-based prevalence surveys. DIGESTIVE DISEASES AND SCIENCES, 51(12), 2292–2301.
- SYMPTOMS AND RISK-FACTORS OF HELICOBACTER-PYLORI INFECTION IN A COHORT OF EPIDEMIOLOGISTS
  Parsonnet, J., Blaser, M. J., PEREZPEREZ, G. I., HARGRETTBEAN, N., & Tauxe, R. V. (1992). SYMPTOMS AND RISK-FACTORS OF HELICOBACTER-PYLORI INFECTION IN A COHORT OF EPIDEMIOLOGISTS. GASTROENTEROLOGY, 102(1), 41–46.
- Gastroenteritis and transmission of Helicobacter pylori infection in households
  Perry, S., Sanchez, M. de la L., Yang, S., Haggerty, T. D., Hurst, P., Perez-Perez, G., & Parsonnet, J. (2006). Gastroenteritis and transmission of Helicobacter pylori infection in households. EMERGING INFECTIOUS DISEASES, 12(11), 1701–8.
- Serum ghrelin levels and risk of subsequent adenocarcinoma of the esophagus
  de Martel, C., Haggerty, T. D., Corley, D. A., Vogelman, J. H., Orentreich, N., & Parsonnet, J. (2007). Serum ghrelin levels and risk of subsequent adenocarcinoma of the esophagus. AMERICAN JOURNAL OF GASTROENTEROLOGY, 102(6), 1166–72.
- Cerebral myiasis associated with angiosarcoma of the scalp: case report.
  Cheshier, S. H., Bababeygy, S. R., Higgins, D., Parsonnet, J., & Huhn, S. L. (2007). Cerebral myiasis associated with angiosarcoma of the scalp: case report. Neurosurgery, 61(1), E167-?
- Estimating disease prevalence using census data
  Choy, M., Switzer, P., de Martel, C., & Parsonnet, J. (2008). Estimating disease prevalence using census data. EPIDEMIOLOGY AND INFECTION, 136(9), 1253–1260.
- Reproducibility of QuantiFERON-TB gold in-tube assay
  Perry, S., Sanchez, L., Yang, S., Agarwal, Z., Hurst, P., & Parsonnet, J. (2008). Reproducibility of QuantiFERON-TB gold in-tube assay. CLINICAL AND VACCINE IMMUNOLOGY, 15(3), 425–32.
- Helicobacter pylori infection and development of pancreatic cancer
  de Martel, C., Llosa, A. E., Friedmana, G. D., Vogelman, J. H., Orentreich, N., Stolzenberg-Solomon, R. Z., & Parsonnet, J. (2008). Helicobacter pylori infection and development of pancreatic cancer. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 17(5), 1188–94.
- Identification of cardioviruses related to Theiler's murine encephalomyelitis virus in human infections
  Chiu, C. Y., Greninger, A. L., Kanada, K., Kwok, T., Fischer, K. F., Runckel, C., … DeRisi, J. L. (2008). Identification of cardioviruses related to Theiler's murine encephalomyelitis virus in human infections. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 105(37), 14124–29.
- HELICOBACTER-PYLORI INFECTION AND THE RISK OF GASTRIC-CARCINOMA
  Parsonnet, J., Friedman, G. D., Vandersteen, D. P., Chang, Y., Vogelman, J. H., Orentreich, N., & Sibley, R. K. (1991). HELICOBACTER-PYLORI INFECTION AND THE RISK OF GASTRIC-CARCINOMA. NEW ENGLAND JOURNAL OF MEDICINE, 325(16), 1127–31.
- POLYMYOSITIS AFTER CIGUATERA TOXIN EXPOSURE
  Stommel, E. W., Parsonnet, J., & Jenkyn, L. R. (1991). POLYMYOSITIS AFTER CIGUATERA TOXIN EXPOSURE. ARCHIVES OF NEUROLOGY, 48(8), 874–877.
- Helicobacter species in cancers of the gallbladder and extrahepatic biliary tract
  de Martel, C., Plummer, M., Parsonnet, J., van Doorn, L.-J., & Franceschi, S. (2009). Helicobacter species in cancers of the gallbladder and extrahepatic biliary tract. BRITISH JOURNAL OF CANCER, 100(1), 194–199.
- Cost-Effectiveness of a Potential Prophylactic Helicobacter pylori Vaccine in the United States
  Rupnow, M. F. T., Chang, A. H., Shachter, R. D., Owens, D. K., & Parsonnet, J. (2009). Cost-Effectiveness of a Potential Prophylactic Helicobacter pylori Vaccine in the United States. JOURNAL OF INFECTIOUS DISEASES, 200(8), 1311–17.
- MULTIFOCAL COLITIS ASSOCIATED WITH AN EPIDEMIC OF CHRONIC DIARRHEA
  JANDA, R. C., Conklin, J. L., Mitros, F. A., & Parsonnet, J. (1991). MULTIFOCAL COLITIS ASSOCIATED WITH AN EPIDEMIC OF CHRONIC DIARRHEA. GASTROENTEROLOGY, 100(2), 458–464.
- Helicobacter pylori and gastric adenocarcinoma
  Herrera, V., & Parsonnet, J. (2009). Helicobacter pylori and gastric adenocarcinoma. CLINICAL MICROBIOLOGY AND INFECTION, 15(11), 971–976.
- Infection with Helicobacter pylori Is Associated with Protection against Tuberculosis
  Perry, S., de Jong, B. C., Solnick, J. V., Sanchez, M. de la L., Yang, S., Lin, P. L., … Parsonnet, J. (2010). Infection with Helicobacter pylori Is Associated with Protection against Tuberculosis. PLOS ONE, 5(1).
- Cultivation and Serological Characterization of a Human Theiler's-Like Cardiovirus Associated with Diarrheal Disease
  Chiu, C. Y., Greninger, A. L., Chen, E. C., Haggerty, T. D., Parsonnet, J., Delwart, E., … Ganem, D. (2010). Cultivation and Serological Characterization of a Human Theiler's-Like Cardiovirus Associated with Diarrheal Disease. JOURNAL OF VIROLOGY, 84(9), 4407–14.
- Required vs. Elective Research and In-Depth Scholarship Programs in the Medical Student Curriculum
  Parsonnet, J., Gruppuso, P. A., Kanter, S. L., & Boninger, M. (2010). Required vs. Elective Research and In-Depth Scholarship Programs in the Medical Student Curriculum. ACADEMIC MEDICINE, 85(3), 405–8.
- Encouraging Scholarship: Medical School Programs to Promote Student Inquiry Beyond the Traditional Medical Curriculum
  Green, E. P., Borkan, J. M., Pross, S. H., Adler, S. R., Nothnagle, M., Parsonnet, J., & Gruppuso, P. A. (2010). Encouraging Scholarship: Medical School Programs to Promote Student Inquiry Beyond the Traditional Medical Curriculum. ACADEMIC MEDICINE, 85(3), 409–418.
- Engaging Students in Dedicated Research and Scholarship During Medical School: The Long-Term Experiences at Duke and Stanford
  Laskowitz, D. T., Drucker, R. P., Parsonnet, J., Cross, P. C., & Gesundheit, N. (2010). Engaging Students in Dedicated Research and Scholarship During Medical School: The Long-Term Experiences at Duke and Stanford. ACADEMIC MEDICINE, 85(3), 419–428.
- HELICOBACTER-PYLORI INFECTION IN INTESTINAL-TYPE AND DIFFUSE-TYPE GASTRIC ADENOCARCINOMAS
  Parsonnet, J., Vandersteen, D., GOATES, J., Sibley, R. K., PRITIKIN, J., & Chang, Y. (1991). HELICOBACTER-PYLORI INFECTION IN INTESTINAL-TYPE AND DIFFUSE-TYPE GASTRIC ADENOCARCINOMAS. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 83(9), 640–643.
- Immediate Incubation Reduces Indeterminate Results for QuantiFERON-TB Gold In-Tube Assay
  Herrera, V., Yeh, E., Murphy, K., Parsonnet, J., & Banaei, N. (2010). Immediate Incubation Reduces Indeterminate Results for QuantiFERON-TB Gold In-Tube Assay. JOURNAL OF CLINICAL MICROBIOLOGY, 48(8), 2672–76.
- Effect of Helicobacter pylori Infection on Symptoms of Gastroenteritis Due to Enteropathogenic Escherichia coli in Adults
  Chang, A. H.-M., Haggerty, T. D., de Martel, C., Leung, C. W.-M., & Parsonnet, J. (2011). Effect of Helicobacter pylori Infection on Symptoms of Gastroenteritis Due to Enteropathogenic Escherichia coli in Adults. DIGESTIVE DISEASES AND SCIENCES, 56(2), 457–64.
- Role of Bacteria in Oncogenesis
  Chang, A. H., & Parsonnet, J. (2010). Role of Bacteria in Oncogenesis. CLINICAL MICROBIOLOGY REVIEWS, 23(4), 837-?
- The impact of mucosal infections on acquisition and progression of tuberculosis
  Perry, S., Hussain, R., & Parsonnet, J. (2011). The impact of mucosal infections on acquisition and progression of tuberculosis. MUCOSAL IMMUNOLOGY, 4(3), 246–251.
- Clinical Application and Limitations of Interferon-gamma Release Assays for the Diagnosis of Latent Tuberculosis Infection
  Herrera, V., Perry, S., Parsonnet, J., & Banaei, N. (2011). Clinical Application and Limitations of Interferon-gamma Release Assays for the Diagnosis of Latent Tuberculosis Infection. CLINICAL INFECTIOUS DISEASES, 52(8), 1031–37.
- Local epidemic history as a predictor of tuberculosis incidence in Saskatchewan Aboriginal communities
  Pepperell, C., Chang, A. H., Wobeser, W., Parsonnet, J., & Hoeppner, V. H. (2011). Local epidemic history as a predictor of tuberculosis incidence in Saskatchewan Aboriginal communities. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 15(7), 899–905.
- ASSOCIATION OF HELICOBACTER-PYLORI INFECTION WITH DYSPEPTIC SYMPTOMS IN PATIENTS UNDERGOING GASTRODUODENOSCOPY
  Strauss, R. M., Wang, T. C., Kelsey, P. B., COMPTON, C. C., Ferraro, M. J., PerezPerez, G., … Blaser, M. J. (1990). ASSOCIATION OF HELICOBACTER-PYLORI INFECTION WITH DYSPEPTIC SYMPTOMS IN PATIENTS UNDERGOING GASTRODUODENOSCOPY. AMERICAN JOURNAL OF MEDICINE, 89(4), 464–469.
- Gastric Cancer Incidence among Hispanics in California: Patterns by Time, Nativity, and Neighborhood Characteristics
  Chang, E. T., Gomez, S. L., Fish, K., Schupp, C. W., Parsonnet, J., DeRouen, M. C., … Glaser, S. L. (2012). Gastric Cancer Incidence among Hispanics in California: Patterns by Time, Nativity, and Neighborhood Characteristics. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 21(5), 709–719.
- Investigation of False-Positive Results Given by the QuantiFERON-TB Gold In-Tube Assay
  Slater, M., Parsonnet, J., & Banaei, N. (2012). Investigation of False-Positive Results Given by the QuantiFERON-TB Gold In-Tube Assay. JOURNAL OF CLINICAL MICROBIOLOGY, 50(9), 3105–7.
- The immune response to tuberculosis infection in the setting of Helicobacter pylori and helminth infections.
  Perry, S., Chang, A. H., Sanchez, L., Yang, S., Haggerty, T. D., & Parsonnet, J. (2013). The immune response to tuberculosis infection in the setting of Helicobacter pylori and helminth infections. Epidemiology and Infection, 141(6), 1232–43.
- Decreasing Intestinal Parasites in Recent Northern California Refugees
  Chang, A. H., Perry, S., Du, J. N. T., Agunbiade, A., Polesky, A., & Parsonnet, J. (2013). Decreasing Intestinal Parasites in Recent Northern California Refugees. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 88(1), 191–97.
- SHIGELLA-DYSENTERIAE TYPE-1 INFECTIONS IN UNITED-STATES TRAVELERS TO MEXICO, 1988
  Parsonnet, J., Greene, K. D., Gerber, A. R., Tauxe, R. V., AGUILAR, O. J. V., & Blake, P. A. (1989). SHIGELLA-DYSENTERIAE TYPE-1 INFECTIONS IN UNITED-STATES TRAVELERS TO MEXICO, 1988. LANCET, 2(8662), 543–545.
- INTERNATIONAL TRAVEL AND THE CHILD YOUNGER THAN 2 YEARS .1. RECOMMENDATIONS FOR IMMUNIZATION
  PREBLUD, S. R., Tsai, T. F., Brink, E. W., Nahlen, B. L., & Parsonnet, J. (1989). INTERNATIONAL TRAVEL AND THE CHILD YOUNGER THAN 2 YEARS .1. RECOMMENDATIONS FOR IMMUNIZATION. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 8(7), 416–425.
- INTERNATIONAL TRAVEL AND THE CHILD YOUNGER THAN 2 YEARS .2. RECOMMENDATIONS FOR PREVENTION OF TRAVELERS DIARRHEA AND MALARIA CHEMOPROPHYLAXIS
  Nahlen, B. L., Parsonnet, J., PREBLUD, S. R., Tsai, T. F., & Brink, E. W. (1989). INTERNATIONAL TRAVEL AND THE CHILD YOUNGER THAN 2 YEARS .2. RECOMMENDATIONS FOR PREVENTION OF TRAVELERS DIARRHEA AND MALARIA CHEMOPROPHYLAXIS. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 8(11), 735–739.
- CHRONIC DIARRHEA ASSOCIATED WITH DRINKING UNTREATED WATER
  Parsonnet, J., Trock, S. C., Bopp, C. A., Wood, C. J., Addiss, D. G., ALAI, F., … Tauxe, R. V. (1989). CHRONIC DIARRHEA ASSOCIATED WITH DRINKING UNTREATED WATER. ANNALS OF INTERNAL MEDICINE, 110(12), 985–991.
- TRICHOSPORON-BEIGELII PERITONITIS
  Parsonnet, J. (1989). TRICHOSPORON-BEIGELII PERITONITIS. SOUTHERN MEDICAL JOURNAL, 82(8), 1062–1063.
- SIMPLE MICROBIOLOGIC DETECTION OF CAMPYLOBACTER-PYLORI
  Parsonnet, J., Welch, K., Compton, C., Strauss, R., Wang, T., Kelsey, P., & Ferraro, M. J. (1988). SIMPLE MICROBIOLOGIC DETECTION OF CAMPYLOBACTER-PYLORI. JOURNAL OF CLINICAL MICROBIOLOGY, 26(5), 948–949.
- BIOLOGIC SEX AS A RISK FACTOR FOR HELICOBACTER-PYLORI INFECTION IN HEALTHY-YOUNG ADULTS
  Replogle, M. L., Glaser, S. L., Hiatt, R. A., & Parsonnet, J. (1995). BIOLOGIC SEX AS A RISK FACTOR FOR HELICOBACTER-PYLORI INFECTION IN HEALTHY-YOUNG ADULTS. AMERICAN JOURNAL OF EPIDEMIOLOGY, 142(8), 856–863.
- FLAGELLAR SEROTYPES OF SALMONELLA-TYPHI IN INDONESIA - RELATIONSHIPS AMONG MOTILITY, INVASIVENESS, AND CLINICAL ILLNESS
  Grossman, D. A., WITHAM, N. D., Burr, D. H., Lesmana, M., Rubin, F. A., SCHOOLNIK, G. K., & Parsonnet, J. (1995). FLAGELLAR SEROTYPES OF SALMONELLA-TYPHI IN INDONESIA - RELATIONSHIPS AMONG MOTILITY, INVASIVENESS, AND CLINICAL ILLNESS. JOURNAL OF INFECTIOUS DISEASES, 171(1), 212–16.
- H pylori and gastric cancer.
  Forman, D., Webb, P., & Parsonnet, J. (1994). H pylori and gastric cancer. Lancet, 343(8891), 243–244.
- THE EPIDEMIOLOGY OF TUBERCULOSIS IN SAN-FRANCISCO - A POPULATION-BASED STUDY USING CONVENTIONAL AND MOLECULAR METHODS
  Small, P. M., Hopewell, P. C., Singh, S. P., Paz, A., Parsonnet, J., Ruston, D. C., … SCHOOLNIK, G. K. (1994). THE EPIDEMIOLOGY OF TUBERCULOSIS IN SAN-FRANCISCO - A POPULATION-BASED STUDY USING CONVENTIONAL AND MOLECULAR METHODS. NEW ENGLAND JOURNAL OF MEDICINE, 330(24), 1703–9.
- GASTRIC ADENOCARCINOMA AND HELICOBACTER-PYLORI INFECTION
  Parsonnet, J. (1994). GASTRIC ADENOCARCINOMA AND HELICOBACTER-PYLORI INFECTION. WESTERN JOURNAL OF MEDICINE, 161(1), 60–60.
- PARASITISM BY THE SLOW BACTERIUM HELICOBACTER-PYLORI LEADS TO ALTERED GASTRIC HOMEOSTASIS AND NEOPLASIA
  Blaser, M. J., & Parsonnet, J. (1994). PARASITISM BY THE SLOW BACTERIUM HELICOBACTER-PYLORI LEADS TO ALTERED GASTRIC HOMEOSTASIS AND NEOPLASIA. JOURNAL OF CLINICAL INVESTIGATION, 94(1), 4–8.
- HELICOBACTER-PYLORI INFECTION AND GASTRIC LYMPHOMA
  Parsonnet, J., Hansen, S., Rodriguez, L., Gelb, A. B., Warnke, R. A., Jellum, E., … Friedman, G. D. (1994). HELICOBACTER-PYLORI INFECTION AND GASTRIC LYMPHOMA. NEW ENGLAND JOURNAL OF MEDICINE, 330(18), 1267–71.
- HELICOBACTER-PYLORI, PEPSINOGEN, AND RISK FOR GASTRIC ADENOCARCINOMA
  Parsonnet, J., Samloff, I. M., Nelson, L. M., Orentreich, N., Vogelman, J. H., & Friedman, G. D. (1993). HELICOBACTER-PYLORI, PEPSINOGEN, AND RISK FOR GASTRIC ADENOCARCINOMA. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2(5), 461–66.
- AZATHIOPRINE HYPERSENSITIVITY MIMICKING SEPSIS IN A PATIENT WITH CROHNS-DISEASE
  Wilson, B. E., & Parsonnet, J. (1993). AZATHIOPRINE HYPERSENSITIVITY MIMICKING SEPSIS IN A PATIENT WITH CROHNS-DISEASE. CLINICAL INFECTIOUS DISEASES, 17(5), 940–941.
- Hemolytic uremic syndrome: clinical picture and bacterial connection.
  Parsonnet, J., & Griffin, P. M. (1993). Hemolytic uremic syndrome: clinical picture and bacterial connection. Current Clinical Topics in Infectious Diseases, 13, 172–187.
- THE ASSOCIATION OF HELICOBACTER-PYLORI WITH GASTRIC-CANCER AND PRENEOPLASTIC GASTRIC-LESIONS IN CHIAPAS, MEXICO
  Guarner, J., Mohar, A., Parsonnet, J., & Halperin, D. (1993). THE ASSOCIATION OF HELICOBACTER-PYLORI WITH GASTRIC-CANCER AND PRENEOPLASTIC GASTRIC-LESIONS IN CHIAPAS, MEXICO. CANCER, 71(2), 297–301.
- HELICOBACTER-PYLORI AND GASTRIC-CANCER
  Parsonnet, J. (1993). HELICOBACTER-PYLORI AND GASTRIC-CANCER. GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 22(1), 89–104.
- PARAQUAT POISONING IN SOUTHERN MEXICO - A REPORT OF 25 CASES
  Tinoco, R., Tinoco, R., Parsonnet, J., & Halperin, D. (1993). PARAQUAT POISONING IN SOUTHERN MEXICO - A REPORT OF 25 CASES. ARCHIVES OF ENVIRONMENTAL HEALTH, 48(2), 78–80.
- CHRONIC IDIOPATHIC DIARRHEA
  Mintz, E. D., Parsonnet, J., & Osterholm, M. T. (1993). CHRONIC IDIOPATHIC DIARRHEA. NEW ENGLAND JOURNAL OF MEDICINE, 328(23), 1713–1714.
- ANOTHER CASE OF POLYMYOSITIS AFTER CIGUATERA TOXIN EXPOSURE
  Stommel, E. W., Jenkyn, L. R., & Parsonnet, J. (1993). ANOTHER CASE OF POLYMYOSITIS AFTER CIGUATERA TOXIN EXPOSURE. ARCHIVES OF NEUROLOGY, 50(6), 571–571.
- THE INCIDENCE OF HELICOBACTER-PYLORI INFECTION
  Parsonnet, J. (1995). THE INCIDENCE OF HELICOBACTER-PYLORI INFECTION. Presented at the Roundtable Meeting on Epidemiology of Helicobacter pylori Infection, HERTFORD,ENGLAND: BLACKWELL SCIENCE LTD.
- Principles of screening and surveillance
  Parsonnet, J., & Axon, A. T. R. (1996). Principles of screening and surveillance. AMERICAN JOURNAL OF GASTROENTEROLOGY, 91(5), 847–849.
- Helicobacter pylori in the stomach - A paradox unmasked
  Parsonnet, J. (1996). Helicobacter pylori in the stomach - A paradox unmasked. NEW ENGLAND JOURNAL OF MEDICINE, 335(4), 278–280.
- Increased risk of Helicobacter pylori associated with birth in wartime and post-war Japan
  Replogle, M. L., Kasumi, W., Ishikawa, K. B., Yang, S. F., Juji, T., Miki, K., … Parsonnet, J. (1996). Increased risk of Helicobacter pylori associated with birth in wartime and post-war Japan. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 25(1), 210–14.
- Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: A mandate for clinical trials
  Parsonnet, J., Harris, R. A., HACK, H. M., & Owens, D. K. (1996). Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: A mandate for clinical trials. LANCET, 348(9021), 150–54.
- Bacterial infection as a cause of cancer
  Parsonnet, J. (1995). Bacterial infection as a cause of cancer. ENVIRONMENTAL HEALTH PERSPECTIVES, 103, 263–268.
- Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy
  Smith, K., & Parsonnet, J. (1997). Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. NEW ENGLAND JOURNAL OF MEDICINE, 336(8), 587–587.
- Should we treat H. pylori infection to prevent gastric cancer?
  Parsonnet, J., Harris, R. A., HACK, H. M., & Owens, D. K. (1997). Should we treat H. pylori infection to prevent gastric cancer? Gastroenterology, 112(3), 1044–45.
- Seroprevalence of CagA-positive strains among Helicobacter pylori-infected, healthy young adults
  Parsonnet, J., Replogle, M., Yang, S. F., & Hiatt, R. (1997). Seroprevalence of CagA-positive strains among Helicobacter pylori-infected, healthy young adults. JOURNAL OF INFECTIOUS DISEASES, 175(5), 1240–42.
- Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection
  Parsonnet, J., Friedman, G. D., Orentreich, N., & VOGELMAN, H. (1997). Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. GUT, 40(3), 297–301.
- Urinary phytoestrogen levels in young women from a multiethnic population
  HORNROSS, P. L., Barnes, S., KIRK, M., Coward, L., Parsonnet, J., & Hiatt, R. A. (1997). Urinary phytoestrogen levels in young women from a multiethnic population. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 6(5), 339–45.
- Molecular mechanisms for inflammation-promoted pathogenesis of cancer - The Sixteenth International Symposium of the Sapporo Cancer Seminar
  Parsonnet, J. (1997). Molecular mechanisms for inflammation-promoted pathogenesis of cancer - The Sixteenth International Symposium of the Sapporo Cancer Seminar. CANCER RESEARCH, 57(16), 3620–3624.
- Risk for gastric lymphoma in persons with CagA(+) and CagA(-) Helicobacter pylori infection
  Witherell, H. L., Hansen, S., Jellum, E., Orentreich, N., Vogelman, J. H., & Parsonnet, J. (1997). Risk for gastric lymphoma in persons with CagA(+) and CagA(-) Helicobacter pylori infection. JOURNAL OF INFECTIOUS DISEASES, 176(6), 1641–1644.
- Epidemiology of gastric non-Hodgkin's lymphoma patients: parallels with Helicobacter pylori.
  Thorburn, C., Rodriguez, L., & Parsonnet, J. (1996). Epidemiology of gastric non-Hodgkin's lymphoma patients: parallels with Helicobacter pylori. Helicobacter, 1(2), 75–78.
- Helicobacter pylori infection and urinary excretion of 8-hydroxy-2-deoxyguanosine, an oxidative DNA adduct
  Witherell, H. L., Hiatt, R. A., Replogle, M., & Parsonnet, J. (1998). Helicobacter pylori infection and urinary excretion of 8-hydroxy-2-deoxyguanosine, an oxidative DNA adduct. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 7(2), 91–96.
- Helicobacter pylori
  Parsonnet, J. (1998). Helicobacter pylori. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 12(1), 185-?
- Gastrin and colorectal cancer: A prospective study
  Thorburn, C. M., Friedman, G. D., Dickinson, C. J., Vogelman, J. H., Orentreich, N., & Parsonnet, J. (1998). Gastrin and colorectal cancer: A prospective study. GASTROENTEROLOGY, 115(2), 275–80.
- Helicobacter pylori: the size of the problem
  Parsonnet, J. (1998). Helicobacter pylori: the size of the problem. Presented at the Educational Training Workshop on Helicobacter pylori, BOLOGNA,ITALY: B M J PUBLISHING GROUP.
- Advances in the prevention and management of traveler's diarrhea.
  Passaro, D. J., & Parsonnet, J. (1998). Advances in the prevention and management of traveler's diarrhea. Current Clinical Topics in Infectious Diseases, 18, 217–236.
- Microbes and Malignancy: Infection as a Cause of Human Cancer
  (1999). Microbes and Malignancy: Infection as a Cause of Human Cancer, (New York).
- Learning about H-pylori transmission dynamics from the distinct patterns of duodenal ulcer and gastric cancer
  Tsugawa, M. F., Shachter, R., Owens, D. K., & Parsonnet, J. (1999). Learning about H-pylori transmission dynamics from the distinct patterns of duodenal ulcer and gastric cancer. GASTROENTEROLOGY, 116(4), A338–A338.
- Predicting the next century of H-pylori prevalence and associated diseases in the United States
  Tsugawa, M. F., Shachter, R., Owens, D. K., & Parsonnet, J. (1999). Predicting the next century of H-pylori prevalence and associated diseases in the United States. GASTROENTEROLOGY, 116(4), A339–A339.
- PREVENTION OF GASTRIC-CANCER - A COST-EFFECTIVENESS ANALYSIS OF SCREENING FOR HELICOBACTER-PYLORI
  HACK, H. M., Harris, R., Owens, D. K., & Parsonnet, J. (1994). PREVENTION OF GASTRIC-CANCER - A COST-EFFECTIVENESS ANALYSIS OF SCREENING FOR HELICOBACTER-PYLORI. CLINICAL RESEARCH, 42(1), A23–A23.
- PREVENTION OF GASTRIC-CANCER - A COST-EFFECTIVENESS ANALYSIS OF SCREENING FOR HELICOBACTER-PYLORI
  HACK, H. M., Harris, R. A., Owens, D. K., & Parsonnet, J. (1994). PREVENTION OF GASTRIC-CANCER - A COST-EFFECTIVENESS ANALYSIS OF SCREENING FOR HELICOBACTER-PYLORI. CLINICAL RESEARCH, 42(2), A226–A226.
- Maternal infection with Helicobacter pylori as a risk factor for infection in children of different ages
  Tamburini, B. A., Tsai, C. J., Garcia, M. I., Sanchez, L., Villacorta, R., Nguyen, Q., … Parsonnet, J. (2001). Maternal infection with Helicobacter pylori as a risk factor for infection in children of different ages. CLINICAL INFECTIOUS DISEASES, 33(7), 1140–1140.
- Changes in gene expression in intermediate endpoints of gastric cancer: A randomized, placebo-controlled trial of Helicobacter pylori eradication therapy.
  Tsai, C. J., Yang, S. F., Tibshirani, R. J., Guarner, J., Mohar, A., Herrera-Goepfert, R., & Parsonnet, J. (2003). Changes in gene expression in intermediate endpoints of gastric cancer: A randomized, placebo-controlled trial of Helicobacter pylori eradication therapy. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 12(11), 1280S–1280S.
- Epidemiology of Helicobacter pylori infection in Northern Californian households with diarrheal diseases
  Rahman, M. M., Asghar, R. J., Tsai, C. J., & Parsonnet, J. (2001). Epidemiology of Helicobacter pylori infection in Northern Californian households with diarrheal diseases. GASTROENTEROLOGY. W B SAUNDERS CO-ELSEVIER INC.
- Vitamin D Deficiency and Tuberculosis Progression
  Talat, N., Perry, S., Parsonnet, J., Dawood, G., & Hussain, R. (2010). Vitamin D Deficiency and Tuberculosis Progression. EMERGING INFECTIOUS DISEASES, 16(5), 853–855.
- The complete genome of klassevirus - a novel picornavirus in pediatric stool
  Greninger, A. L., Runckel, C., Chiu, C. Y., Haggerty, T., Parsonnet, J., Ganem, D., & DeRisi, J. L. (2009). The complete genome of klassevirus - a novel picornavirus in pediatric stool. VIROLOGY JOURNAL, 6.
- Infectious Diseases in Children and Body Mass Index in Young Adults
  Suh, G., Ley, C., & Parsonnet, J. (2012). Infectious Diseases in Children and Body Mass Index in Young Adults. EMERGING INFECTIOUS DISEASES, 18(9), 1490–92.
- Comparison of stool and serologic tests for Helicobacter pylori infection in infants
  Garcia, M. I., Haggerty, T. D., & Parsonnet, J. (2001). Comparison of stool and serologic tests for Helicobacter pylori infection in infants. GASTROENTEROLOGY, 120(5), A492–A492.
- p53 overexpression and cell proliferation index in gastric cancer by anatomic subsite.
  Shibata, A., Garcia, M. I., Longacre, T. A., Puligandla, B., Parsonnet, J., Vogelman, J., … Habel, L. A. (2000). p53 overexpression and cell proliferation index in gastric cancer by anatomic subsite. AMERICAN JOURNAL OF EPIDEMIOLOGY, 151(11), S77–S77.
- REVERSAL OF INTESTINAL METAPLASIA AFTER TREATMENT OF HELICOBACTER-PYLORI INFECTION
  HACK, H. M., Fennerty, M. B., Sampliner, R., Egbert, B., Triadafilopoulos, G., & Parsonnet, J. (1994). REVERSAL OF INTESTINAL METAPLASIA AFTER TREATMENT OF HELICOBACTER-PYLORI INFECTION. GASTROENTEROLOGY, 106(4), A87–A87.
- Challenges with QuantiFERON-TB Gold Assay for Large-Scale, Routine Screening of U.S. Healthcare Workers
  Slater, M. L., Welland, G., Pai, M., Parsonnet, J., & Banaei, N. (2013). Challenges with QuantiFERON-TB Gold Assay for Large-Scale, Routine Screening of U.S. Healthcare Workers. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 188(8), 1005–1010.
- Urinary Triclosan is Associated with Elevated Body Mass Index in NHANES.
  Lankester, J., Patel, C., Cullen, M. R., Ley, C., & Parsonnet, J. (2013). Urinary Triclosan is Associated with Elevated Body Mass Index in NHANES. PloS One, 8(11).
- Maternal prepregnancy body mass index and risk of spontaneous preterm birth.
  Shaw, G. M., Wise, P. H., Mayo, J., Carmichael, S. L., Ley, C., Lyell, D. J., … Gould, J. B. (2014). Maternal prepregnancy body mass index and risk of spontaneous preterm birth. Paediatric and Perinatal Epidemiology, 28(4), 302–11.
- Discovery of a Novel Polyomavirus in Acute Diarrheal Samples from Children
  Yu, G., Greninger, A. L., Isa, P., Phan, T. G., Angel Martinez, M., Sanchez, M. de la L., … Chiu, C. Y. (2012). Discovery of a Novel Polyomavirus in Acute Diarrheal Samples from Children. PLOS ONE, 7(11).
- Acute Helicobacter pylori infection is followed by an increase in diarrheal disease among Peruvian children
  Passaro, D. J., TAYLOR, D. N., MEZA, R., Cabrera, L., Gilman, R. H., & Parsonnet, J. (2001). Acute Helicobacter pylori infection is followed by an increase in diarrheal disease among Peruvian children. PEDIATRICS, 108(5), U61–U68.
- Helicobacter pylori and epidemic Vibrio cholerae 01 infection in Peru
  Shahinian, M. L., Passaro, D. J., Swerdlow, D. L., Mintz, E. D., Rodriguez, M., & Parsonnet, J. (2000). Helicobacter pylori and epidemic Vibrio cholerae 01 infection in Peru. LANCET, 355(9201), 377–378.
- Helicobacter pylori and gastroesophageal reflux disease: A case-control study
  Corley, D. A., Kubo, A., Levin, T. R., Block, G., Habel, L., Rumore, G., … Parsonnet, J. (2008). Helicobacter pylori and gastroesophageal reflux disease: A case-control study. HELICOBACTER, 13(5), 352–360.
- Helicobacter pylori infection and the risk of Barrett's oesophagus: a community-based study
  Corley, D. A., Kubo, A., Levin, T. R., Block, G., Habel, L., Zhao, W., … Parsonnet, J. (2008). Helicobacter pylori infection and the risk of Barrett's oesophagus: a community-based study. GUT, 57(6), 727–733.
- Discovery of a novel polyomavirus in acute diarrheal samples from children.
  Yu, G., Greninger, A. L., Isa, P., Phan, T. G., Martínez, M. A., de la Luz Sanchez, M., … Chiu, C. Y. (2012). Discovery of a novel polyomavirus in acute diarrheal samples from children. PloS One, 7(11).
- Comparison of two methods - regression predictive model and intake shift model - for adjusting self-reported dietary recall of total energy intake of populations.
  Lankester, J., Perry, S., & Parsonnet, J. (2014). Comparison of two methods - regression predictive model and intake shift model - for adjusting self-reported dietary recall of total energy intake of populations. Frontiers in Public Health, 2, 249-?
- In vitro immunomodulation for enhancing T cell-based diagnosis of Mycobacterium tuberculosis infection
  Slater, M., Minh-Chi Tran, M. C., Platt, L., Luu, L. T., Phan, H. T., Pham, P. T., … Banaei, N. (2015). In vitro immunomodulation for enhancing T cell-based diagnosis of Mycobacterium tuberculosis infection. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 83(1), 41–45.
- Stanford's Outcomes Research in Kids (STORK): a prospective study of healthy pregnant women and their babies in Northern California.
  Ley, C., Sanchez, M. delaL., Mathur, A., Yang, S., Sundaram, V., & Parsonnet, J. (2016). Stanford's Outcomes Research in Kids (STORK): a prospective study of healthy pregnant women and their babies in Northern California. BMJ Open, 6(4).
- Safety and acceptability of Lactobacillus reuteri DSM 17938 and Bifidobacterium longum subspecies infantis 35624 in Bangladeshi infants: a phase I randomized clinical trial.
  Hoy-Schulz, Y. E., Jannat, K., Roberts, T., Zaidi, S. H., Unicomb, L., Luby, S., & Parsonnet, J. (2016). Safety and acceptability of Lactobacillus reuteri DSM 17938 and Bifidobacterium longum subspecies infantis 35624 in Bangladeshi infants: a phase I randomized clinical trial. BMC Complementary and Alternative Medicine, 16(1), 44-?
- Effect of long-term antibiotic use on weight in adolescents with acne.
  Contopoulos-Ioannidis, D. G., Ley, C., Wang, W., Ma, T., Olson, C., Shi, X., … Parsonnet, J. (2016). Effect of long-term antibiotic use on weight in adolescents with acne. Journal of Antimicrobial Chemotherapy, 71(4), 1098–1105.
- Crossover Control Study of the Effect of Personal Care Products Containing Triclosan on the Microbiome.
  Poole, A. C., Pischel, L., Ley, C., Suh, G., Goodrich, J. K., Haggerty, T. D., … Parsonnet, J. (2016). Crossover Control Study of the Effect of Personal Care Products Containing Triclosan on the Microbiome. MSphere, 1(3).
- A survey of probiotic use practices among patients at a tertiary medical centre.
  Draper, K., Ley, C., & Parsonnet, J. (2017). A survey of probiotic use practices among patients at a tertiary medical centre. Beneficial Microbes, 8(3), 345–51.
- Household triclosan and triclocarban effects on the infant and maternal microbiome.
  Ribado, J. V., Ley, C., Haggerty, T. D., Tkachenko, E., Bhatt, A. S., & Parsonnet, J. (2017). Household triclosan and triclocarban effects on the infant and maternal microbiome. EMBO Molecular Medicine, 9(12), 1732–41.
- Triclosan and triclocarban exposure and thyroid function during pregnancy-A randomized intervention
  Ley, C., Pischel, L., & Parsonnet, J. (2017). Triclosan and triclocarban exposure and thyroid function during pregnancy-A randomized intervention. REPRODUCTIVE TOXICOLOGY, 74, 143–49.
- Triclosan and triclocarban exposure, infectious disease symptoms and antibiotic prescription in infants-A community-based randomized intervention.
  Ley, C., Sundaram, V., Sanchez, M. de, Desai, M., & Parsonnet, J. (2018). Triclosan and triclocarban exposure, infectious disease symptoms and antibiotic prescription in infants-A community-based randomized intervention. PloS One, 13(6), e0199298.
- Evidence of inflated exclusive breastfeeding estimates from a clinical trial in Bangladesh
  Roberts, T. J., Hoy-Schulz, Y. E., Jannat, K., & Parsonnet, J. (2018). Evidence of inflated exclusive breastfeeding estimates from a clinical trial in Bangladesh. INTERNATIONAL BREASTFEEDING JOURNAL, 13, 39.
- Circulating Inflammation-related Markers and Advanced Gastric Premalignant Lesions.
  Song, M., Rabkin, C. S., Torres, J., Kemp, T. J., Zabaleta, J., Pinto, L. A., … Camargo, M. C. (2018). Circulating Inflammation-related Markers and Advanced Gastric Premalignant Lesions. Journal of Gastroenterology and Hepatology.
- Shaping of infant B cell receptor repertoires by environmental factors and infectious disease.
  Nielsen, S. C., Roskin, K. M., Jackson, K. J., Joshi, S. A., Nejad, P., Lee, J.-Y., … Boyd, S. D. (2019). Shaping of infant B cell receptor repertoires by environmental factors and infectious disease. Science Translational Medicine, 11(481).
- Reply to "Triclocarban and Health: the Jury Is Still Out".
  Pischel, L., Poole, A. C., Ley, C., Suh, G., Goodrich, J. K., Haggerty, T. D., … Parsonnet, J. (2016). Reply to "Triclocarban and Health: the Jury Is Still Out". MSphere, 1(6).
- Prevention of gastric cancer.
  Herrero, R., Parsonnet, J., & Greenberg, E. R. (2014). Prevention of gastric cancer. JAMA, 312(12), 1197–8.
- Circulating inflammation-related markers and advanced gastric premalignant lesions
  Song, M., Rabkin, C. S., Torres, J., Kemp, T. J., Zabaleta, J., Pinto, L. A., … Camargo, M. C. (2019). Circulating inflammation-related markers and advanced gastric premalignant lesions. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 34(5), 852–56.
- Shaping of infant B cell receptor repertoires by environmental factors and infectious disease
  Nielsen, S. C. A., Roskin, K. M., Jackson, K. J. L., Joshi, S. A., Nejad, P., Lee, J.-Y., … Boyd, S. D. (2019). Shaping of infant B cell receptor repertoires by environmental factors and infectious disease. SCIENCE TRANSLATIONAL MEDICINE, 11(481).
- Vitamin D status and risk of incident tuberculosis disease: A nested case-control study, systematic review, and individual-participant data meta-analysis.
  Aibana, O., Huang, C.-C. C., Aboud, S., Arnedo-Pena, A., Becerra, M. C., Bellido-Blasco, J. B., … Murray, M. B. (2019). Vitamin D status and risk of incident tuberculosis disease: A nested case-control study, systematic review, and individual-participant data meta-analysis. PLoS Medicine, 16(9), e1002907.
- Time for Helicobacter pylori eradication.
  Parsonnet, J. (2019). Time for Helicobacter pylori eradication. The Lancet. Infectious Diseases, 19(10), 1042–43.
- Increased T Cell Differentiation and Cytolytic Function in Bangladeshi Compared to American Children
  Wager, L. E., Bolen, C. R., Sigel, N., Angel, C. J. L., Guan, L., Kirkpatrick, B. D., … Davis, M. M. (2019). Increased T Cell Differentiation and Cytolytic Function in Bangladeshi Compared to American Children. FRONTIERS IN IMMUNOLOGY, 10.
- Increased T Cell Differentiation and Cytolytic Function in Bangladeshi Compared to American Children.
  Wagar, L. E., Bolen, C. R., Sigal, N., Lopez Angel, C. J., Guan, L., Kirkpatrick, B. D., … Davis, M. M. (2019). Increased T Cell Differentiation and Cytolytic Function in Bangladeshi Compared to American Children. Frontiers in Immunology, 10, 2239.
- Combating gastric cancer in Alaska Native people: An expert and community symposium: Alaska Native Gastric Cancer Symposium.
  Nolen, L. D., Vindigni, S. M., Parsonnet, J., Bruce, M. G., Martinson, H. A., Thomas, T. K., … Melkonian, S. (2019). Combating gastric cancer in Alaska Native people: An expert and community symposium: Alaska Native Gastric Cancer Symposium. Gastroenterology.
- Recall accuracy of weekly automated surveys of health care utilization and infectious disease symptoms among infants over the first year of life.
  Ley, C., Willis, L., de la Luz Sanchez, M., & Parsonnet, J. (2019). Recall accuracy of weekly automated surveys of health care utilization and infectious disease symptoms among infants over the first year of life. PloS One, 14(12), e0226623.
- Decreasing human body temperature in the United States since the industrial revolution.
  Protsiv, M., Ley, C., Lankester, J., Hastie, T., & Parsonnet, J. (2020). Decreasing human body temperature in the United States since the industrial revolution. ELife, 9.
- Gut microbiota plasticity is correlated with sustained weight loss on a low-carb or low-fat dietary intervention
  Grembi, J. A., Nguyen, L. H., Haggerty, T. D., Gardner, C. D., Holmes, S. P., & Parsonnet, J. (2020). Gut microbiota plasticity is correlated with sustained weight loss on a low-carb or low-fat dietary intervention. Scientific Reports, 10.
- The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis
  Martinez, L., Cords, O., Horsburgh, C. R., & Andrews, J. R. (2020). The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis. LANCET, 395(10228), 973–84.
- Symptomatic SARS-CoV-2 infections display specific IgG Fc structures.
  Chakraborty, S., Edwards, K., Buzzanco, A. S., Memoli, M. J., Sherwood, R., Mallajosyula, V., … Wang, T. T. (2020). Symptomatic SARS-CoV-2 infections display specific IgG Fc structures. MedRxiv : the Preprint Server for Health Sciences.
- A Summary of the 2020 Gastric Cancer Summit at Stanford University.
  Huang, R. J., Koh, H., & Hwang, J. H. (2020). A Summary of the 2020 Gastric Cancer Summit at Stanford University. Gastroenterology.
- Metagenomic sequencing of stool samples in Bangladeshi infants: virome association with poliovirus shedding after oral poliovirus vaccination.
  Tan, S. K., Granados, A. C., Bouquet, J., Hoy-Schulz, Y. E., Green, L., Federman, S., … Chiu, C. Y. (2020). Metagenomic sequencing of stool samples in Bangladeshi infants: virome association with poliovirus shedding after oral poliovirus vaccination. Scientific Reports, 10(1), 15392.
- Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study.
  Anand, S., Montez-Rath, M., Han, J., Bozeman, J., Kerschmann, R., Beyer, P., … Chertow, G. M. (2020). Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study. Lancet (London, England).
- Interferon-gamma release assay for accurate detection of SARS-CoV-2 T cell response.
  Murugesan, K., Jagannathan, P., Pham, T. D., Pandey, S., Bonilla, H. F., Jacobson, K., … Banaei, N. (2020). Interferon-gamma release assay for accurate detection of SARS-CoV-2 T cell response. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America.
- Proinflammatory IgG Fc structures in patients with severe COVID-19
  Chakraborty, S., Gonzales, J., Edwards, K., Mallajosyulla, V., Buzzanco, A. S., Sherwood, R., … Tan, G. S. (2020). Proinflammatory IgG Fc structures in patients with severe COVID-19. Nature Immunology.
- SARS-CoV-2 Seroprevalence in Healthcare Personnel in Northern California Early in the COVID-19 Pandemic.
  Rosser, J. I., Roltgen, K., Dymock, M., Shepard, J., Martin, A., Hogan, C. A., … Holubar, M. (2020). SARS-CoV-2 Seroprevalence in Healthcare Personnel in Northern California Early in the COVID-19 Pandemic. Infection Control and Hospital Epidemiology, 1–27.
- Frequent occurrence of triclosan hydroxylation in mammals: A combined theoretical and experimental investigation.
  Zhang, H., Sanidad, K. Z., Zhu, L., Parsonnet, J., Haggerty, T. D., Zhang, G., & Cai, Z. (2020). Frequent occurrence of triclosan hydroxylation in mammals: A combined theoretical and experimental investigation. Journal of Hazardous Materials, 407, 124803.
- Temperature Measurement at Well-Child Visits in the United States.
  Dang, R., Schroeder, A. R., Patel, A. I., Parsonnet, J., & Wang, M. (2021). Temperature Measurement at Well-Child Visits in the United States. The Journal of Pediatrics.
- Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trial.
  Jagannathan, P., Andrews, J. R., Bonilla, H., Hedlin, H., Jacobson, K. B., Balasubramanian, V., … Singh, U. (2021). Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trial. Nature Communications, 12(1), 1967.
- Laboratory correlates of SARS-CoV-2 seropositivity in a nationwide sample of patients on dialysis in the U.S.
  Anand, S., Montez-Rath, M. E., Han, J., Garcia, P., Bozeman, J., Kerschmann, R., … Chertow, G. M. (2021). Laboratory correlates of SARS-CoV-2 seropositivity in a nationwide sample of patients on dialysis in the U.S. PloS One, 16(4), e0249466.
- Shared B cell memory to coronaviruses and other pathogens varies in human age groups and tissues.
  Yang, F., Nielsen, S. C., Hoh, R. A., Roltgen, K., Wirz, O. F., Haraguchi, E., … Boyd, S. D. (2021). Shared B cell memory to coronaviruses and other pathogens varies in human age groups and tissues. Science (New York, N.Y.).
- SARS-CoV-2 Vaccine Acceptability in Patients on Hemodialysis: A Nationwide Survey.
  Garcia, P., Montez-Rath, M. E., Moore, H., Flotte, J., Fults, C., Block, M. S., … Anand, S. (2021). SARS-CoV-2 Vaccine Acceptability in Patients on Hemodialysis: A Nationwide Survey. Journal of the American Society of Nephrology : JASN.
- Metabolic fate of environmental chemical triclocarban in colon tissues: roles of gut microbiota involved.
  Wang, G., Zhang, H., Zhang, J., Sanidad, K. Z., Yeliseyev, V., Parsonnet, J., … Zhang, G. (2021). Metabolic fate of environmental chemical triclocarban in colon tissues: roles of gut microbiota involved. The Science of the Total Environment, 787, 147677.
- Serial SARS-CoV-2 Receptor-Binding Domain Antibody Responses in Patients Receiving Dialysis.
  Anand, S., Montez-Rath, M. E., Han, J., Garcia, P., Cadden, L. C., Hunsader, P., … Parsonnet, J. (2021). Serial SARS-CoV-2 Receptor-Binding Domain Antibody Responses in Patients Receiving Dialysis. Annals of Internal Medicine.
- SARS-COV-2 VACCINE ACCEPTABILITY IN PATIENTS ON DIALYSIS: A NATIONWIDE SURVEY
  Garcia, P., Montez-Rath, M., Moore, H., Flotte, J., Fults, C., Block, M., … Anand, S. (2021). SARS-COV-2 VACCINE ACCEPTABILITY IN PATIENTS ON DIALYSIS: A NATIONWIDE SURVEY. AMERICAN JOURNAL OF KIDNEY DISEASES. W B SAUNDERS CO-ELSEVIER INC.
- SARS-CoV-2 subgenomic RNA kinetics in longitudinal clinical samples
  Verma, R., Kim, E., Martinez, G., Jagannathan, P., Rustagi, A., Parsonnet, J., … Andrews, J. (2021). SARS-CoV-2 subgenomic RNA kinetics in longitudinal clinical samples. Open Forum Infectious Diseases.
- Antibody Response to COVID-19 Vaccination in Patients Receiving Dialysis.
  Anand, S., Montez-Rath, M., Han, J., Garcia, P., Cadden, L. C., Hunsader, P., … Chertow, G. (2021). Antibody Response to COVID-19 Vaccination in Patients Receiving Dialysis. Journal of the American Society of Nephrology : JASN.
- Antibody Response to COVID-19 vaccination in Patients Receiving Dialysis.
  Anand, S., Montez-Rath, M. E., Han, J., Garcia, P., Cadden, L. C., Hunsader, P., … Chertow, G. M. (2021). Antibody Response to COVID-19 vaccination in Patients Receiving Dialysis. MedRxiv : the Preprint Server for Health Sciences.
- Post-vaccination SARS-CoV-2 infections and incidence of presumptive B.1.427/B.1.429 variant among healthcare personnel at a northern California academic medical center.
  Jacobson, K. B., Pinsky, B. A., Montez Rath, M. E., Wang, H., Miller, J. A., Skhiri, M., … Holubar, M. (2021). Post-vaccination SARS-CoV-2 infections and incidence of presumptive B.1.427/B.1.429 variant among healthcare personnel at a northern California academic medical center. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America.
- Post-vaccination SARS-CoV-2 infections and incidence of the B.1.427/B.1.429 variant among healthcare personnel at a northern California academic medical center.
  Jacobson, K. B., Pinsky, B. A., Rath, M. E., Wang, H., Miller, J. A., Skhiri, M., … Holubar, M. (2021). Post-vaccination SARS-CoV-2 infections and incidence of the B.1.427/B.1.429 variant among healthcare personnel at a northern California academic medical center. MedRxiv : the Preprint Server for Health Sciences.
- Estimated SARS-CoV-2 Seroprevalence in US Patients Receiving Dialysis 1 Year After the Beginning of the COVID-19 Pandemic.
  Anand, S., Montez-Rath, M., Han, J., Cadden, L. C., Hunsader, P., Kerschmann, R., … Chertow, G. M. (2021). Estimated SARS-CoV-2 Seroprevalence in US Patients Receiving Dialysis 1 Year After the Beginning of the COVID-19 Pandemic. JAMA Network Open, 4(7), e2116572.
- The COVID-19 Outpatient Pragmatic Platform Study (COPPS): Study design of a multi-center pragmatic platform trial.
  Bunning, B., Hedlin, H., Purington, N., Sundaram, V., Kapphahn, K., Weng, Y., … Desai, M. (2021). The COVID-19 Outpatient Pragmatic Platform Study (COPPS): Study design of a multi-center pragmatic platform trial. Contemporary Clinical Trials, 106509.
- COVID19 Vaccine Type and Humoral Immune Response in Patients Receiving Dialysis.
  Garcia, P., Anand, S., Han, J., Montez-Rath, M., Sun, S., Shang, T., … Abra, G. (2021). COVID19 Vaccine Type and Humoral Immune Response in Patients Receiving Dialysis. Journal of the American Society of Nephrology : JASN.
- SARS-CoV-2 Vaccine Antibody Response and Breakthrough Infection in Patients Receiving Dialysis.
  Anand, S., Montez-Rath, M. E., Han, J., Garcia, P., Cadden, L. C., Hunsader, P., … Parsonnet, J. (1800). SARS-CoV-2 Vaccine Antibody Response and Breakthrough Infection in Patients Receiving Dialysis. Annals of Internal Medicine.
- SARS-CoV-2 vaccine antibody response and breakthrough infection in dialysis.
  Anand, S., Montez-Rath, M. E., Han, J., Garcia, P., Cadden, L. C., Hunsader, P., … Parsonnet, J. (2021). SARS-CoV-2 vaccine antibody response and breakthrough infection in dialysis. MedRxiv : the Preprint Server for Health Sciences.
- Inflammatory but not respiratory symptoms are associated with ongoing upper airway viral shedding in outpatients with uncomplicated COVID-19.
  Jacobson, K. B., Purington, N., Parsonnet, J., Andrews, J., Balasubramanian, V., Bonilla, H., … Jagannathan, P. (2021). Inflammatory but not respiratory symptoms are associated with ongoing upper airway viral shedding in outpatients with uncomplicated COVID-19. Diagnostic Microbiology and Infectious Disease, 102(3), 115612.
- Microbial enzymes induce colitis by reactivating triclosan in the mouse gastrointestinal tract.
  Zhang, J., Walker, M. E., Sanidad, K. Z., Zhang, H., Liang, Y., Zhao, E., … Zhang, G. (1800). Microbial enzymes induce colitis by reactivating triclosan in the mouse gastrointestinal tract. Nature Communications, 13(1), 136.
- Long Term Accuracy of SARS-CoV-2 Interferon-? Release Assay and its Application in Household Investigation.
  Murugesan, K., Jagannathan, P., Altamirano, J., Maldonado, Y. A., Bonilla, H. F., Jacobson, K. B., … Banaei, N. (2022). Long Term Accuracy of SARS-CoV-2 Interferon-? Release Assay and its Application in Household Investigation. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America.
- Early immune responses have long-term associations with clinical, virologic, and immunologic outcomes in patients with COVID-19.
  Hu, Z., van der Ploeg, K., Chakraborty, S., Arunachalam, P., Mori, D., Jacobson, K., … Jagannathan, P. (2022). Early immune responses have long-term associations with clinical, virologic, and immunologic outcomes in patients with COVID-19. Research Square.
- SARS-CoV-2 infection during the Omicron surge among patients receiving dialysis: the role of circulating receptor-binding domain antibodies and vaccine doses.
  Montez-Rath, M. E., Garcia, P., Han, J., Cadden, L. C., Hunsader, P., Morgan, C., … Chertow, G. M. (2022). SARS-CoV-2 infection during the Omicron surge among patients receiving dialysis: the role of circulating receptor-binding domain antibodies and vaccine doses. MedRxiv : the Preprint Server for Health Sciences.
- SARS-CoV-2 Booster Vaccine Response among Patients Receiving Dialysis.
  Garcia, P., Han, J., Montez-Rath, M., Sun, S., Shang, T., Parsonnet, J., … Abra, G. (2022). SARS-CoV-2 Booster Vaccine Response among Patients Receiving Dialysis. Clinical Journal of the American Society of Nephrology : CJASN.
- Favipiravir for treatment of outpatients with asymptomatic or uncomplicated COVID-19: a double-blind randomized, placebo-controlled, phase 2 trial.
  Holubar, M., Subramanian, A., Purington, N., Hedlin, H., Bunning, B., Walter, K. S., … Maldonado, Y. (2022). Favipiravir for treatment of outpatients with asymptomatic or uncomplicated COVID-19: a double-blind randomized, placebo-controlled, phase 2 trial. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America.
- Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection.
  Natarajan, A., Zlitni, S., Brooks, E. F., Vance, S. E., Dahlen, A., Hedlin, H., … Bhatt, A. S. (2022). Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection. Med (New York, N.Y.).
- TNF-alpha+ CD4+ Tcells dominate the SARS-CoV-2 specific T cell response in COVID-19 outpatients and are associated with durable antibodies.
  van der Ploeg, K., Kirosingh, A. S., Mori, D. A., Chakraborty, S., Hu, Z., Sievers, B. L., … Jagannathan, P. (2022). TNF-alpha+ CD4+ Tcells dominate the SARS-CoV-2 specific T cell response in COVID-19 outpatients and are associated with durable antibodies. Cell Reports. Medicine, 100640.
- CalScope: Monitoring Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence From Vaccination and Prior Infection in Adults and Children in California May 2021-July 2021.
  Mehrotra, M. L., Lim, E., Lamba, K., Kamali, A., Lai, K. W., Meza, E., … Jain, S. (2022). CalScope: Monitoring Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence From Vaccination and Prior Infection in Adults and Children in California May 2021-July 2021. Open Forum Infectious Diseases, 9(7), ofac246.
- SARS-CoV-2 Infection during the Omicron Surge among Patients Receiving Dialysis: The Role of Circulating Receptor-Binding Domain Antibodies and Vaccine Doses.
  Montez-Rath, M. E., Garcia, P., Han, J., Cadden, L. C., Hunsader, P., Morgan, C., … Anand, S. (2022). SARS-CoV-2 Infection during the Omicron Surge among Patients Receiving Dialysis: The Role of Circulating Receptor-Binding Domain Antibodies and Vaccine Doses. Journal of the American Society of Nephrology : JASN.
- Validity of at-home rapid antigen lateral flow assay and artificial intelligence read to detect SARS-CoV-2.
  Richardson, S., Kohn, M. A., Bollyky, J., & Parsonnet, J. (2022). Validity of at-home rapid antigen lateral flow assay and artificial intelligence read to detect SARS-CoV-2. Diagnostic Microbiology and Infectious Disease, 104(3), 115763.
- Early immune markers of clinical, virological, and immunological outcomes in patients with COVID-19: a multi-omics study.
  Hu, Z., van der Ploeg, K., Chakraborty, S., Arunachalam, P. S., Mori, D. A., Jacobson, K. B., … Jagannathan, P. (2022). Early immune markers of clinical, virological, and immunological outcomes in patients with COVID-19: a multi-omics study. ELife, 11.
- Microbiota-mediated reactivation of triclosan oxidative metabolites in colon tissues.
  Zhang, H., Sanidad, K. Z., Zhang, J., Wang, G., Zhang, R., Hu, C., … Cai, Z. (2022). Microbiota-mediated reactivation of triclosan oxidative metabolites in colon tissues. Journal of Hazardous Materials, 445, 130509.
- Gestational diabetes is driven by microbiota-induced inflammation months before diagnosis.
  Pinto, Y., Frishman, S., Turjeman, S., Eshel, A., Nuriel-Ohayon, M., Shrossel, O., … Koren, O. (2023). Gestational diabetes is driven by microbiota-induced inflammation months before diagnosis. Gut.
- Characteristics of California Emergency Departments in Centers for Disease Control and Prevention-Designated HIV Priority Counties.
  Bennett, C. L., Clay, C. E., Siddiqi, K. A., Olatosi, B. A., Parsonnet, J., & Camargo, J. C. (2023). Characteristics of California Emergency Departments in Centers for Disease Control and Prevention-Designated HIV Priority Counties. The Journal of Emergency Medicine.
- Longitudinal comparison of the developing gut virome in infants and their mothers.
  Walters, W. A., Granados, A. C., Ley, C., Federman, S., Stryke, D., Santos, Y., … Chiu, C. Y. (2023). Longitudinal comparison of the developing gut virome in infants and their mothers. Cell Host & Microbe, 31(2), 187.
- Feasibility and Acceptability of SARS-CoV-2 Screening among Patients Receiving Hemodialysis: A Pilot Study.
  Anand, S., Montez-Rath, M., Varkila, M., Yu, X., Block, M., Brillhart, S., … Block, G. (2023). Feasibility and Acceptability of SARS-CoV-2 Screening among Patients Receiving Hemodialysis: A Pilot Study. Clinical Journal of the American Society of Nephrology : CJASN.
- Evaluation of acebilustat, a selective inhibitor of leukotriene B4 biosynthesis, for treatment of outpatients with mild-moderate COVID-19 disease: A randomized, double-blind, placebo- controlled Phase 2 trial.
  Levitt, J. E., Hedlin, H., Duong, S., Lu, D., Lee, J., Bunning, B., … Rogers, A. J. (2023). Evaluation of acebilustat, a selective inhibitor of leukotriene B4 biosynthesis, for treatment of outpatients with mild-moderate COVID-19 disease: A randomized, double-blind, placebo- controlled Phase 2 trial. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America.
- Recruitment into antibody prevalence studies: a randomized trial of postcards vs. letters as invitations.
  Ley, C., Duan, H., & Parsonnet, J. (2023). Recruitment into antibody prevalence studies: a randomized trial of postcards vs. letters as invitations. BMC Medical Research Methodology, 23(1), 170.
- Use of Wastewater Metrics to Track COVID-19 in the US.
  Varkila, M. R., Montez-Rath, M. E., Salomon, J. A., Yu, X., Block, G. A., Owens, D. K., … Anand, S. (2023). Use of Wastewater Metrics to Track COVID-19 in the US. JAMA Network Open, 6(7), e2325591.
- Defining Usual Oral Temperature Ranges in Outpatients Using an Unsupervised Learning Algorithm.
  Ley, C., Heath, F., Hastie, T., Gao, Z., Protsiv, M., & Parsonnet, J. (2023). Defining Usual Oral Temperature Ranges in Outpatients Using an Unsupervised Learning Algorithm. JAMA Internal Medicine.
- Comparison of US emergency departments by HIV priority jurisdiction designation: A case for geographically targeted screening in teaching hospitals.
  Bennett, C. L., Detsky, A. S., Clay, C. E., Espinola, J. A., Parsonnet, J., & Camargo, C. A. (2023). Comparison of US emergency departments by HIV priority jurisdiction designation: A case for geographically targeted screening in teaching hospitals. PloS One, 18(10), e0292869.
- Use of wastewater metrics to track COVID-19 in the U.S.: a national time-series analysis over the first three quarters of 2022.
  Varkila, M., Montez-Rath, M., Salomon, J., Yu, X., Block, G., Owens, D. K., … Anand, S. (2023). Use of wastewater metrics to track COVID-19 in the U.S.: a national time-series analysis over the first three quarters of 2022. MedRxiv : the Preprint Server for Health Sciences.
- A modified Michaelis-Menten equation estimates growth from birth to 3 years in healthy babies in the US.
  Walters, W., Ley, C., Hastie, T., Ley, R., & Parsonnet, J. (2023). A modified Michaelis-Menten equation estimates growth from birth to 3 years in healthy babies in the US. Research Square.
- A modified Michaelis-Menten equation estimates growth from birth to 3 years in healthy babies in the USA.
  Walters, W. A., Ley, C., Hastie, T., Ley, R. E., & Parsonnet, J. (2024). A modified Michaelis-Menten equation estimates growth from birth to 3 years in healthy babies in the USA. BMC Medical Research Methodology, 24(1), 27.
- Observations of Respiratory Syncytial Virus (RSV) Nucleic Acids in Wastewater Solids Across the United States in the 2022-2023 Season: Relationships with RSV Infection Positivity and Hospitalization Rates
  Zulli, A., Varkila, M. R. J., Parsonnet, J., Wolfe, M. K., & Boehm, A. B. (2024). Observations of Respiratory Syncytial Virus (RSV) Nucleic Acids in Wastewater Solids Across the United States in the 2022-2023 Season: Relationships with RSV Infection Positivity and Hospitalization Rates. ACS ES&T WATER.
- Monthly Sulfadoxine-Pyrimethamine During Pregnancy Prevents Febrile Respiratory Illnesses: A Secondary Analysis of a Malaria Chemoprevention Trial in Uganda.
  Lee, J. J., Kakuru, A., Jacobson, K. B., Kamya, M. R., Kajubi, R., Ranjit, A., … Roh, M. E. (2024). Monthly Sulfadoxine-Pyrimethamine During Pregnancy Prevents Febrile Respiratory Illnesses: A Secondary Analysis of a Malaria Chemoprevention Trial in Uganda. Open Forum Infectious Diseases, 11(4), ofae143.
- Observations of Respiratory Syncytial Virus (RSV) Nucleic Acids in Wastewater Solids Across the United States in the 2022-2023 Season: Relationships with RSV Infection Positivity and Hospitalization Rates.
  Zulli, A., Varkila, M. R., Parsonnet, J., Wolfe, M. K., & Boehm, A. B. (2024). Observations of Respiratory Syncytial Virus (RSV) Nucleic Acids in Wastewater Solids Across the United States in the 2022-2023 Season: Relationships with RSV Infection Positivity and Hospitalization Rates. ACS ES&T Water, 4(4), 1657–1667.
- Using Science to Reduce Firearm Injuries and Deaths.
  Cunningham, R., Rosenberg, M., Corbin, T., Branas, C., Buggs, S. A., Haring, S., … Weston, B. (2023). Using Science to Reduce Firearm Injuries and Deaths. NAM Perspectives, 2023.
- CalScope: methodology and lessons learned for conducting a remote statewide SARS-CoV-2 seroprevalence study in California using an at-home dried blood spot collection kit and online survey.
  Lim, E., Mehrotra, M. L., Lamba, K., Kamali, A., Lai, K. W., Meza, E., … Jain, S. (2024). CalScope: methodology and lessons learned for conducting a remote statewide SARS-CoV-2 seroprevalence study in California using an at-home dried blood spot collection kit and online survey. BMC Medical Research Methodology, 24(1), 120.
- Acceptance of SARS-CoV-2 Surveillance Testing Among Patients Receiving Dialysis: A Cluster Randomized Trial.
  Montez-Rath, M., Varkila, M., Yu, X., Brillhart, S., Morgan, C., Leppink, A., … Block, G. A. (2024). Acceptance of SARS-CoV-2 Surveillance Testing Among Patients Receiving Dialysis: A Cluster Randomized Trial. JAMA Network Open, 7(9), e2434159.
- Detection and quantification of human immunodeficiency virus-1 (HIV-1) total nucleic acids in wastewater settled solids from two California communities.
  Wolfe, M. K., Varkila, M. R., Zulli, A., Parsonnet, J., & Boehm, A. B. (2024). Detection and quantification of human immunodeficiency virus-1 (HIV-1) total nucleic acids in wastewater settled solids from two California communities. Applied and Environmental Microbiology, e0147724.
- Implementing Oral Antibiotics for Bone and Joint Infections: Lessons Learned and Opportunities for Improvement.
  Hawkins, M. R., Thottacherry, E., Juthani, P., Aronson, J., Chang, A., Amanatullah, D. F., … Furukawa, D. (2024). Implementing Oral Antibiotics for Bone and Joint Infections: Lessons Learned and Opportunities for Improvement. Open Forum Infectious Diseases, 11(12), ofae683.
- Influence of environmental exposures on T follicular helper cell function and implications on immunity: a comparison of Bangladeshi and American children.
  Van Fossen, D. M., Cho, H., Wagar, L. E., Ma, J. Z., Parsonnet, J., Haque, R., … Petri, W. A. (2025). Influence of environmental exposures on T follicular helper cell function and implications on immunity: a comparison of Bangladeshi and American children. MBio, e0398024.
- Vaccination Strategies in Patients Receiving Dialysis: Should We Watch the Clock?
  Subramanian, N., Yu Xue, Varkila, M., Block, G. A., Parsonnet, J., Chertow, G. M., … Montez-Rath, M. E. (2024). Vaccination Strategies in Patients Receiving Dialysis: Should We Watch the Clock? JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. AMER SOC NEPHROLOGY.

View More Publications

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Closed Trials

Specializing In

Infectious Diseases

Practice Locations

Infectious Diseases Clinic in Palo Alto Palo Alto, CA

Palo Alto, CA

Infectious Diseases Clinic in Palo Alto

211 Quarry Rd, Fl 2 Ste 202

Palo Alto , CA 94304

(650) 736-5200

More Clinic Information

Important Information about Our Organizations and Physician Affiliation

Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.

Patient Ratings

(4 Ratings)

Overall Rating

5.0/5

View Ratings by Category

5.0/5

Friendliness

5.0/5

Explanations

5.0/5

Listens

5.0/5

Care provider's efforts to include you in decisions about your care

5.0/5

Recommended to others

0.0/5

Wait times

How Our Ratings Work

The Patients Ratings and comments are gathered from our Patient Satisfaction Survey and displayed in their entirety.

Patient Satisfaction Survey Disclaimer

Patient Reviews

(47 reviews)

Dr. Schoolnik is absolutely fantastic. Such a kind doctor! Grateful to be able to see him.

Dec 2024

•

Verified SHC Patient

Excellent

Aug 2024

•

Verified SHC Patient

I appreciate her expertise. She sounds very familiar with my situation. She explained why the bacteria forms as the PH raises to a 7 from a 4. She has confirmed what others Drs. Have been telling me. I wish there was a cure for what I have. I will try Estradiol again.

Jun 2024

•

Verified SHC Patient

Very friendly person. Made me feel at ease

Jun 2024

•

Verified SHC Patient

Excellent.

Jun 2024

•

Verified SHC Patient

Julie Parsonnet was excellent! She made sure I didnâ€™t mind being asked questions by the doctor candidate she is working with (& he was great), and made sure I knew sheâ€™d be back to discuss things with me. She also made sure I knew I could contact her again w/any questions or concerns I might have later. I LOVE Stanford!

Mar 2024

•

Verified SHC Patient

Excellent Doctor and very knowledgeable and ready to address your concern about the infectious disease.

Feb 2024

•

Verified SHC Patient

She was very nice and listened to my concerns.

Jul 2023

•

Verified SHC Patient

Dr. Was fabulous.

Apr 2023

•

Verified SHC Patient

Fantastic doctor! I am so glad I could get an appointment o see her.

Mar 2023

•

Verified SHC Patient

She is a Great Doctor

Dec 2022

•

Verified SHC Patient

She was great

Aug 2022

•

Verified SHC Patient

Very attentive, considerate, caring. thorough, excellent at what she does.

Jul 2022

•

Verified SHC Patient

Was generally concerned and interested in all aspects of my case and well being. Showed thoughtfulness and thoroughness.

Jun 2022

•

Verified SHC Patient

She always try to answer all patientâ€™s questions

May 2022

•

Verified SHC Patient

Thank you for your care, really enjoyed meeting you!

May 2022

•

Verified SHC Patient

This dr literally saved my life. She is amazing. She ALWAYS goes above and beyond. The inpatient team at the hospital is usually excellent and I donâ€™t typically care most of the time for the outpatient care but I had Dr. Parsonnet both inside and out and she is a stand out Dr. anyone who has her is very blessed and she literally has saved and changed my life I cannot thank her enough she is a true asset to the Stanford facility

May 2022

•

Verified SHC Patient

She is amazing, heard my concerns and committed to finding a solution.

Mar 2022

•

Verified SHC Patient

Julie was very thorough and provided all the answers to my questions.

Feb 2022

•

Verified SHC Patient

Julie parsonnet is a very nice doctor

Sep 2021

•

Verified SHC Patient

She was incredibly connected with me and details of my case in every sense.. I look forward to the opportunity to work with her in the future.

Aug 2021

•

Verified SHC Patient

Extremely personable, professional and knowledgeable.

Jun 2021

•

Verified SHC Patient

I contracted a C-Difficile infection twice a few years ago and again one month ago due to prophylactic antibiotics (such as amoxicillin) prescribed to prevent post-surgery complications. My concern was heightened with the recurrence of the last infection and the need of antibiotics in the upcoming dental surgeries. I contacted the Stanford Infection Disease Clinic and requested video visit with Dr. Parsonnet uniquely qualified to advise on the issues of my concern. The visit was highly informative and productive. She appreciated my concerns and addressed them one by one with utmost clarity. I will be guided by her detailed recommendations. I am immensely grateful to Dr. Parsonnet for her generous help.

Jun 2021

•

Verified SHC Patient

Dr. is awesome to work with!

Jun 2021

•

Verified SHC Patient

Great doctor, but would rate low on appointment availability

Jun 2021

•

Verified SHC Patient

Excellent and very thorough.

May 2021

•

Verified SHC Patient

I really appreciate her plans to discuss my continued problems with the other specialists who have provided care.

May 2021

•

Verified SHC Patient

Absolutely the best doctor in all ways - intelligent, caring, gives constructive advice, explains clearly, warm bedside manners, etc. etc.

Apr 2021

•

Verified SHC Patient

Dr Parsonnet was wonderful, knowledgeable and answered all my questions. I had a clear idea of the plan of care.

Apr 2021

•

Verified SHC Patient

Dr. Parsonnet is WONDERFUL- thank you!

Sep 2020

•

Verified SHC Patient

Dr. Parsonnet was outstanding. I so appreciate her knowledge and sensitivity to my concerns. She is an exceptional physician.

Apr 2019

•

Verified SHC Patient

Dr. Parsonnet answered all questions I had for her. She made me feel at ease and relaxed.

Mar 2019

•

Verified SHC Patient

The doctor was fantastic. I loved her attitude and humor. I was born at Stanford and love this medical staff.

Mar 2019

•

Verified SHC Patient

Dr. Parsonnet is one of the best doctors I have ever had. She goes above and beyond, during my last visit she contacted two other doctors to get support for me in nutrition, recommending a diet change to support my kidney health. She called on a Saturday to update me on my recent labs! Amazing, caring doctor!

Feb 2019

•

Verified SHC Patient

Dr. Parsonnet is a great doctor who spent time explaining things to me.

Mar 2018

•

Verified SHC Patient

No problem. Satisfied.

Sep 2017

•

Verified SHC Patient

The doctors explained every question and answers to where I understood. I felt very good talking to them. Actually I felt at home, not very many doctor's appt. are comfortable.

Sep 2017

•

Verified SHC Patient

The ID tem in general lacks bedside manner. Even Dr. Blackburn's team.

Jul 2017

•

Verified SHC Patient

This visit was MUCH better than the 1st less wait time to see dr. & the dr. was much more helpful.

Jul 2017

•

Verified SHC Patient

Dr. Parsonnet offered to attend a follow-up visit I had scheduled w/Dr. Kwong to eliminate one extra trip to Stanford from my home in Santa Cruz. Very kind and considerate.

Jan 2017

•

Verified SHC Patient

Wonderful person, thoughtful, well prepared, good listener, excellent or reaching out to other express around the country.

Oct 2016

•

Verified SHC Patient

Julie Parsonnet is the best physician I have ever seen. I could tell she truly cared about me and would check up on me personally. Her personal touch of caring combined with her very strong knowledge make her truly amazing!!

Sep 2016

•

Verified SHC Patient

Dr. Multani & Dr. Parsonnet are both awesome. Very knowledgeable. I trust them both I will miss Dr. Multani.

Jun 2016

•

Verified SHC Patient

Doctor did not have all info on my status - but appreciated info I shared with her. She was interrupted during my visit but seemed to stay focused.

May 2016

•

Verified SHC Patient

I've told everyone what a great experience this was.

Mar 2016

•

Verified SHC Patient

Dr. Parsonnet is exactly how all Dr.'s should be.

Sep 2015

•

Verified SHC Patient

Dr. Parsonnet is "GREAT."

Feb 2014

•

Verified SHC Patient

View More Patient Reviews

Referring Physicians

PHYSICIAN HELPLINE

Phone: 1-866-742-4811
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.

Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.

You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.

Send referrals online
Place radiology and lab orders
View referral status
Access medical records

Learn More About MedLink

LOG INTO MEDLINK

New to MyHealth?

ALREADY HAVE AN ACCESS CODE?

DON'T HAVE AN ACCESS CODE?

NEED MORE DETAILS?

MyHealth for Mobile

Julie Parsonnet

Infectious diseases doctor

Get In Touch

Biography

Professional Summary

Education & Certifications

Honors & Awards

Memberships

Administrative Appointments

Publications

Clinical Trials

Specializing In

Practice Locations

Infectious Diseases Clinic in Palo Alto Palo Alto, CA

Infectious Diseases Clinic in Palo Alto

Important Information about Our Organizations and Physician Affiliation

Patient Ratings

How Our Ratings Work

Patient Reviews

(47 reviews)

Referring Physicians

PHYSICIAN HELPLINE

New to MyHealth?

ALREADY HAVE AN ACCESS CODE?

DON'T HAVE AN ACCESS CODE?

NEED MORE DETAILS?

MyHealth for Mobile

WELCOME BACK

Julie Parsonnet

Infectious diseases doctor

Get In Touch

Biography

Professional Summary

Education & Certifications

Honors & Awards

Memberships

Administrative Appointments

Publications

Clinical Trials

Specializing In

Practice Locations

Infectious Diseases Clinic in Palo Alto Palo Alto, CA

Infectious Diseases Clinic in Palo Alto

Important Information about Our Organizations and Physician Affiliation

Patient Ratings

How Our Ratings Work

Patient Reviews

(47 reviews)

Referring Physicians

PHYSICIAN HELPLINE